Oxeia Biopharmaceuticals
San Diego, US · Founded 2014
Oxeia Biopharma develops therapeutics for concussion and brain injury treatment, focusing on moving beyond conservative management toward active clinical interventions.
Founders & leadership
Oxeia Biopharmaceuticals was founded in 2014 by Kartik Shah and Amit Munshi.
KS
Kartik ShahCo-founder
AM
Amit MunshiCo-founder
MW
Michael WyandCEO
Reported raises · per SEC filings
Form D private placements$310K disclosed across 1 round · 2014
▶$310KraisedJun 2014 · 5 investors · PharmaceuticalsRule 506(b)
▶$310KraisedJun 2014 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kartik ShahExecutive Officer, Director, Promoter
- Amit MunshiExecutive Officer, Director, Promoter
- Offering amount
- $310K
- Amount sold
- $310K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Oxeia Biopharmaceuticals do?
- Oxeia Biopharma develops therapeutics for concussion and brain injury treatment, focusing on moving beyond conservative management toward active clinical interventions.
- Who founded Oxeia Biopharmaceuticals?
- Oxeia Biopharmaceuticals was founded by Kartik Shah, Amit Munshi in 2014.
- How much funding has Oxeia Biopharmaceuticals raised?
- Oxeia Biopharmaceuticals has disclosed $310K raised across 1 round.
- Where is Oxeia Biopharmaceuticals headquartered?
- Oxeia Biopharmaceuticals is headquartered in San Diego, US.